Skip to content

Profound Medical PROF Free cash flow yield

Free cash flow yield at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
1.7%+0.7pp
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
-8.3%-3.1pp
Bioventus logo
BioventusBVS
16.4%+12.4pp
Globus Medical logo
Globus MedicalGMED
5.2%0.0pp

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Calculated from Profound Medical’s reported figures.

Based on trailing twelve months.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's free cash flow yield?
Profound Medical (PROF) reported free cash flow yield of -13.8% in Q4 2025.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.